RxDoctor Payments DataLook up a doctor →

Roger Friedman, MD

Allergy · Westerville, OHNPI 1336147982

Payments from drug & device makers

$154,950in general payments, 2019–2025

Across 1,126 payments — averaging $137.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$46K
  • Sanofi$32K
  • GSK$27K
  • Regeneron Healthcare Solutions, Inc.$17K
  • Genentech USA, Inc.$11K
  • Amgen$6K
  • plus $16K from 36 others

What the payments were for

  • Consulting fees$3,8312%
  • Speaking & faculty fees$122,98579%
  • Travel & lodging$3,5902%
  • Food & beverage$24,25516%
  • Education$2880%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few allergy providers in Ohioto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$163,462
Medicare patients
435
Services billed
10,036

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HaegardaC1 Esterase Inhibitor14$705,575
OrladeyoBerotralstat Hydrochloride13$535,333
Dupixent PenDupilumab23$141,915
Dupixent SyringeDupilumab22$85,167
Spiriva RespimatTiotropium Bromide72$54,539
XolairOmalizumab15$48,210
Breo ElliptaFluticasone/Vilanterol72$44,641
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$39,695
DuleraMometasone/Formoterol29$20,228
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$16,296
SymbicortBudesonide/Formoterol Fumarate42$14,150
Arnuity ElliptaFluticasone Furoate33$12,470
Fluticasone Propionate HfaFluticasone Propionate32$11,455
Qvar RedihalerBeclomethasone Dipropionate31$10,765
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate59$9,279

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
CSL BehringHaegarda$2,128$705,57514 claims
Biocryst US Sales Co., LLCOrladeyo$261$535,33313 claims
GSKBreo Ellipta, Trelegy Ellipta, Arnuity Ellipta$27,050$96,806142 claims
Boehringer IngelheimSpiriva Respimat$216$54,53972 claims
AstraZenecaBreztri Aerosphere, Symbicort, Pulmicort Flexhaler$45,563$35,19267 claims
MerckDulera$15$20,22829 claims
Hikma Pharmaceuticals USARyaltris, Epinephrine$16$11,10740 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$161$10,76531 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy providers in Ohioon file to place this against a meaningful peer group, so we don't.

Other allergy in Westerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →